Charles River expands early discovery services

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/JK1991)
(Image: Getty/JK1991)
Charles River has upped to its early discovery capabilities with the addition of high-throughput technologies and expanded pharmacokinetic services.

According to Charles River, it is the first contract research organization (CRO) to provide clients access to Apricot Designs' Dual Arm (ADDA) system in North America and Europe.

Designed for drug discovery, the system is a high-speed autosampler for liquid chromatography/mass spectrometry (LC/MS).

“Apricot Designs’ dual arm autosampler was designed with early discovery scientists in mind,” ​said Felix H. Yiu, founder and CEO, Apricot Designs, Inc. in a press release. “It enables seamless integration with LC/MS systems, accelerating the laboratory research process and yielding the best results.”

Charles River has also geographically expanded its pharmacokinetic (PK) capabilities in San Francisco and 's-Hertogenbosch, The Netherlands.

“The early discovery industry is seeing a marked shift towards a better understanding of the underlying biology of candidate compounds. Both HT-ADME and PK technologies are critical to that understanding, and to developing more successful candidates in early discovery,”​ explained Ian Waddell, PhD, executive director, biology, Charles River.

Related news

Show more

Related products

show more

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Related suppliers

Follow us


View more